<DOC>
	<DOC>NCT00787319</DOC>
	<brief_summary>To define what procedures were used for the diagnosis and monitoring of the treatment age-related macular degeneration (AMD). What is the effect of the Macugen, compliance with Macugen treatment, safety profile of Macugen, final physician assessment of treatment with Macugen.</brief_summary>
	<brief_title>Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice</brief_title>
	<detailed_description>no sampling</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>age over 18 years old patients with neovascular agerelated macular degeneration enrollment to study is fully on physician decision in compliance with current SPC Patient who did not meet indication according to SPC Macugen.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Ophthalmology</keyword>
	<keyword>Age-related macular degeneration</keyword>
	<keyword>outpatients</keyword>
</DOC>